News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Savient Pharmaceuticals, Inc. (SVNT) Reports Third Quarter 2012 Financial Results



11/9/2012 9:23:30 AM

BRIDGEWATER, N.J., Nov. 8, 2012 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (SVNT) today reported financial results for the three and nine months ended September 30, 2012, which reflects the Company's continuing commercialization of KRYSTEXXA ® (pegloticase) in the U.S. Savient ended the quarter with approximately $116.2 million in cash and short-term investments.

Read at Yahoo Finance


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES